Skip to main content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Too Many U.S. Babies Still Sleep in Positions That Raise SIDS Risk

THURSDAY, Dec. 12, 2024 -- Despite decades of campaigns highlighting the "baby on back" recommendation for safe infant sleep, 12% of 4-month-old babies in the...

Model Including Polygenic Risk, Polysocial Score Improves CHD Risk Prediction

THURSDAY, Dec. 12, 2024 -- A prediction model incorporating a polygenic risk score (PRS) and polysocial score (PSS), including social determinants of health...

SABCS: Imlunestrant Tied to Improved PFS for ER-Positive, HER2-Negative Breast Cancer With ESR1 Mutations

THURSDAY, Dec. 12, 2024 -- For patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer...

Too Much Screen Time Harms Preschoolers' Sleep, Behavior

THURSDAY, Dec. 12, 2024 -- Too much screen time can sabotage preschoolers' sleep, potentially turning them into terrors around the house, a new study...

Global Incidence, Prevalence High for Genital Herpes Simplex Virus Infections

THURSDAY, Dec. 12, 2024 -- The incidence and prevalence of genital herpes simplex virus (HSV) type 1 and 2 infections are high worldwide, contributing to the...

Low-Dose Oral Minoxidil Effective for Alopecia in Breast Cancer

THURSDAY, Dec. 12, 2024 -- Low-dose oral minoxidil (LDOM) is effective for alopecia in patients with breast cancer, according to a letter to the editor...

2004 to 2021 Saw Increase in Distant-Stage Breast Cancer Incidence

THURSDAY, Dec. 12, 2024 -- During 2004 to 2021, there was an increase in distant-stage breast cancer incidence rates at presentation, according to a study...

U.S. Overdose Deaths Fell 17% in Just One Year

FRIDAY, Dec. 13, 2024 -- In news that suggest the U.S. opioid epidemic may be easing, drug overdose deaths fell 17% between July 2023 and July 2024. Per new...

Study Warns That Cats Might Be Bird Flu Carriers

THURSDAY, Dec. 12, 2024 -- Picture this: a beloved cat, playful and healthy one day, falls mysteriously ill the next. Soon after, the shocking culprit is...

Only a Third of U.S. Kids Have Gotten Flu Shots

THURSDAY, Dec. 12, 2024 -- Despite a record number of American children dying from the flu last year, the percentage of kids getting their flu shots keeps...

Imfinzi Approved in the US as First and Only Immunotherapy Regimen for Patients with Limited-Stage Small Cell Lung Cancer

5 December 2024 -- AstraZeneca’s Imfinzi (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung...

FDA Grants Accelerated Approval to Bizengri (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) [Merus, the Company, we, or our], a clinical-stage...

Cytokinetics Announces FDA Acceptance of New Drug Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy

SOUTH SAN FRANCISCO, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food & Drug...

FDA Approves Yesintek (ustekinumab-kfce), a Biosimilar to Stelara

Bengaluru, Karnataka, India, December 01, 2024 -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE...

FDA Approves Rapiblyk (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting

Vienna, -- November 27th 2024 -- AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug Administration...

Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia

NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative...

Satsuma Pharmaceuticals and SNBL Receive FDA Acceptance of NDA Resubmission of STS101 for the Acute Treatment of Migraine With or Without Aura

DURHAM, N.C., Nov. 26, 2024 /PRNewswire/ -- Satsuma Pharmaceuticals, Inc., a late-stage biopharmaceutical company, and its corporate parent, Shin Nippon...

Soleno Therapeutics Announces FDA Extension of Review Period for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome

REDWOOD CITY, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical...

FDA Approves Imkeldi (imatinib) Oral Solution for the Treatment of Certain Forms of Leukemia and Other Cancers

CAMBRIDGE, Mass.-- November 25, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that the FDA...

Arrowhead Pharmaceuticals Submits New Drug Application to U.S. FDA for Plozasiran for the Treatment of Familial Chylomicronemia Syndrome

PASADENA, Calif.–(BUSINESS WIRE)–Nov. 18, 2024– Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it submitted a New Drug...

Lilly's Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as Monotherapy and in Combination with Verzenio® (abemaciclib) in Patients with ER+, HER2- Advanced Breast Cancer

INDIANAPOLIS, Dec. 11, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 EMBER-3 study of imlunestrant, an...

NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain

December 10, 2024 -- The antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults with mild to moderate...

Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza

GAITHERSBURG, Md., Dec. 10, 2024. Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M adjuvant, today announced that the first...

uniQure Announces Alignment with FDA on Key Elements of Accelerated Approval Pathway for AMT-130 in Huntington’s Disease

LEXINGTON, Mass. and AMSTERDAM, Dec. 10, 2024 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative...

Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End

DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully...

Browse by news type

Drugs.com Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Disclaimer

This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.